Identification of protein biomarkers associated with cardiac ischemia by a proteomic approach

References

• Alexanian R, Barlogie B, Fritsche H. (1985). Beta 2 microglobulin in multiple myoloma. Amm J Hematol 20:345–51
   PubMed Web of Science ®Google Scholar
• Altwegg LA, Neidhart M, Hersberger M, et al. (2007). Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. Eur Heart J 28:941–8
   PubMed Web of Science ®Google Scholar
• Baumann M, Schmaderer C, Burkhardt K, et al. (2011). MRP8/14 is associated with systemic inflammation in stable coronary atherosclerosis in men. Eur J Clin Invest 41:1261–7
   Google Scholar
• Birjmohun RS, Dallinga-Thie G, Kuivenhoven JA, et al. (2007). Apolipoprotein A-II is inversely associated with risk of future coronary artery disease. Circulation 116:2029–35
   PubMed Web of Science ®Google Scholar
• Bisoendial RJ, Boekholdt S, Vergeer M, et al. (2010). C-reactive protein is a mediator of cardiovascular disease. Eur Heart J 31:2087–91
   PubMed Web of Science ®Google Scholar
• Butterfield AM, Luan P, Witcher DR, et al. (2010). A dual-monoclonal sandwich ELISA specific for hepcidin-25. Clin Chem 56:1725–32
   PubMed Web of Science ®Google Scholar
• Cooke JP, Wilson AM. (2010). Biomarkers of peripheral arterial disease. J Am Coll Cardiol 55:2017–23
   PubMed Web of Science ®Google Scholar
• Cowie MR, Mendez GF. (2002). BNP and congestive heart failure. Prog Cardiovasc Dis 44:293–321
   PubMed Web of Science ®Google Scholar
• Danesh J, Wheeler JG, Hircshfield GM, et al. (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–97
   PubMed Web of Science ®Google Scholar
• de Seny D, Fillet M, Meuwis MA, et al. (2005). Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum 52:3801–12
   PubMed Web of Science ®Google Scholar
• de Seny D, Sharif M, Fillet M, et al. (2011). Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis. Ann Rheum Dis 70:1144–52
   PubMed Web of Science ®Google Scholar
• Ganz T. (2011). Hepcidin and iron regulation, 10 years later. Blood 117:4425–33
   PubMed Web of Science ®Google Scholar
• Ganz T, Olbina G, Girelli D, et al. (2008). Immunoassay for human serum hepcidin. Blood 112:4292–7
   PubMed Web of Science ®Google Scholar
• Geurts P, Fillet M, de Seny D, et al. (2005). Proteomic mass spectra classification using decision tree based ensemble methods. Bioinformatics 21:3138–45
   Google Scholar
• Harb TS, Zareba W, Moss AJ, et al. (2002). Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction. Am J Cardiol 89:216–21
   Google Scholar
• Jankowska EA, Malyszko J, Ardehali H, et al. (2013). Iron status in patients with chronic heart failure. Eur Heart J 34:827–34
   PubMed Web of Science ®Google Scholar
• Johnson BD, Kip KE, Marroquin OC, et al. (2004). Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109:726–32
   PubMed Web of Science ®Google Scholar
• Julve J, Escola-Gil JC, Rotllan N, et al. (2010). Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome. Arterioscler Thromb Vasc Biol 30:232–8
   PubMed Web of Science ®Google Scholar
• Kaplan KL, Owen J. (1981). Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 57:199–202
   PubMed Web of Science ®Google Scholar
• Kouz R, Rheaume E, Berry C, et al. (2011). Circulating VEGF concentrations are independently predictive of coronary artery disease severity measured by quantitative coronary angiography in patients with stable angina. J Am Coll Cardiol 57:E1464. doi:10.1016/S0735-1097(11)61464-2
   Google Scholar
• Labarrere CA, Zaloga GP. (2004). C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am J Med 117:499–507
   PubMed Web of Science ®Google Scholar
• Liao H, Wu J, Kuhn E, et al. (2004). Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 50:3792–803
   PubMed Web of Science ®Google Scholar
• Mair J. (2002). Role of cardiac natriuretic peptide testing in heart failure. Clinical chemistry 48:977–8
   Google Scholar
• Marcovina SM, Crea F, Davignon C, et al. (2007). Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools. J Intern Med 261:214–34
   Google Scholar
• Meuwis MA, Fillet M, Geurts P, et al. (2007). Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochem Pharm 73:1422–33
   PubMed Web of Science ®Google Scholar
• Mills EJ, Wu P, Chong G, et al. (2011). Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials. QJM 104:109–24
   PubMed Web of Science ®Google Scholar
• Morrow DA, Braunwald E. (2003). Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation 108:250–2
   PubMedGoogle Scholar
• Morrow DA, Rifai N, Antman EM, et al. (2000). Serum amyloid A predicts early mortality in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol 35:358–62
   PubMed Web of Science ®Google Scholar
• Murao SM. (1994). Two calcium-binding protein, MRP8 and MRP14: a protein complex associated with neutrophil and monocytes activation. Acta Histochem Cytochem 27:107–16
   Google Scholar
• Ogawa, H, Yasue H, Oshima S, et al. (1989). Circadian variation of plasma fibrinopeptide A level in patients with variant angina. Circulation 80:1617–26
   PubMed Web of Science ®Google Scholar
• Park JP, Park MK, Yun JW. (2011). Proteomic biomarkers for diagnosis in acute myocardial infarction. Biomarkers 16:1–11
   PubMed Web of Science ®Google Scholar
• Panteghini M, Bonetti G, Pagani F, et al. (2005). Measurement of troponin I 48 h after admission as a tool to rule out impaired left ventricular function in patients with a first myocardial infarction. Clin Chem Lab Med 43:848–54
   Google Scholar
• Perna ER, Macin SM, Canella JP, et al. (2004). Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification. Circulation 110:2376–82
   PubMed Web of Science ®Google Scholar
• Peronnet E, Becquart L, Martinez J, et al. (2007). Isoelectric point determination of cardiac troponin I forms present in plasma from patients with myocardial infarction. Clin Chim Acta 377:243–7
   Google Scholar
• Pinet F, Beseme O, Cieniewski-Bernard C, et al. (2008). Predicting left ventricular remodeling after a first myocardial infarction by plasma proteome analysis. Proteomics 8:1798–808
   Google Scholar
• Sabatine MS, Morrow DA, de Lemos JA, et al. (2002). Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105:1760–3
   PubMed Web of Science ®Google Scholar
• Saharinen P, Tammela T, Karkkainen MJ, Alitalo K. (2004). Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25:387–95
   PubMed Web of Science ®Google Scholar
• Simonis G, Mueller K, Schwarz P, et al. (2010). The iron-regulatory peptide hepcidin is upregulated in the ischemic and in the remote myocardium after myocardial infarction. Peptides 31:1786–90
   Google Scholar
• Song C, Shen Y, Yamen E, et al. (2009). Serum amyloid A may potentiate prothrombotic and proinflammatory events in acute coronary syndromes. Atherosclerosis 202:596–604
   PubMed Web of Science ®Google Scholar
• Srinivasan SR, Berenson GS. (1995). Serum apolipoproteins A-I and B as markers of coronary artery disease risk in early life: the Bogalusa Heart Study. Clin Chem 41:159–64
   Google Scholar
• Sullivan JL. (2007). Macrophage iron, hepcidin, and atherosclerotic plaque stability. Exp Biol Med (Maywood) 232:1014–20
   PubMed Web of Science ®Google Scholar
• Surendran RP, Visser ME, Heemelaar S, et al. (2012). Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. J Intern Med 272:185–96
   PubMed Web of Science ®Google Scholar
• Syväranta S, Helske S, Lappalainen J, et al. (2012). Lymphangiogenesis in aortic valve stenosis–novel regulatory roles for valvular myofibroblasts and mast cells. Atherosclerosis 221:366–74
   Google Scholar
• Testa U, Pannitteri G, Condorelli GL. (2008). Vascular endothelial growth factors in cardiovascular medicine. J Cardiovasc Med (Hagerstown) 9:1190–221
   Google Scholar
• Tousoulis D, Antoniades C, Stefanadis C. (2007). Assessing inflammatory status in cardiovascular disease. Heart 93:1001–7
   Google Scholar
• Vogl T, Tenbrock K, Ludwig S, et al. (2007). Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13:1042–9
   PubMed Web of Science ®Google Scholar
• Walldius G, Jungner I. (2004). Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med 255:188–205
   PubMed Web of Science ®Google Scholar
• Walldius G, Jungner I. (2005). Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy. Eur Heart J 26:210–12
   PubMed Web of Science ®Google Scholar
• Wilson AM, Kimura E, Harada RK, et al. (2007). Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation 116:1396–403
   PubMed Web of Science ®Google Scholar
• Wiviott SD, de Lemos JA, Morrow A. (2004). Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes. Clin Chim Acta 346:119–28
   PubMed Web of Science ®Google Scholar
• Zakynthinos E, Pappa N. (2009). Inflammatory biomarkers in coronary artery disease. Journal of cardiology 53:317–33
   PubMed Web of Science ®Google Scholar